-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ECfFfQvtQ6RLfiNUfj8C9jPuQYYLppQBDSi/GaD/1aB6h0SCeb08/csYgQSBg57G DaekN4yerW70hTJIszturA== 0000950116-99-001673.txt : 19990902 0000950116-99-001673.hdr.sgml : 19990902 ACCESSION NUMBER: 0000950116-99-001673 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990901 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PREMIER RESEARCH WORLDWIDE LTD CENTRAL INDEX KEY: 0001026650 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 223264604 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-53083 FILM NUMBER: 99704556 BUSINESS ADDRESS: STREET 1: 124 SOUTH 15TH ST CITY: PHILADELPHIA STATE: PA ZIP: 19172 BUSINESS PHONE: 2159720420 MAIL ADDRESS: STREET 1: 124 SOUTH 15TH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19102 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MORGANROTH JOEL M D CENTRAL INDEX KEY: 0001053449 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 124 SOUTH 15TH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19102 BUSINESS PHONE: 2129720420 MAIL ADDRESS: STREET 1: 1040 STONEY LANE CITY: GLADWYNE STATE: PA ZIP: 19035 SC 13G 1 SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* PREMIER RESEARCH WORLDWIDE, LTD. (Name of Issuer) Common Stock (Title of Class of Securities) 740568 10 0 (CUSIP Number) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and a subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on the following pages) Page 1 of 4 Pages - ------------------------------- CUSIP NO. 740568 10 0 - ------------------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON Joel Morganroth, M.D. ###-##-#### - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (See Instructions) (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 495,175 NUMBER OF SHARES ---------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER OWNED BY EACH 9,600 REPORTING PERSON ---------------------------------------------------- WITH 7 SOLE DISPOSITIVE POWER 495,175 ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 9,600 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,004,000 (disclaims beneficial ownership of 495,225 shares) - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 14.7% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- -2- Item 4: Ownership: Item 4 of the Schedule 13G of Joel Morganroth, M.D. is hereby amended to read in its entirety as follows: As of August 31, 1999, Dr. Morganroth, as described more fully below, may be deemed to own beneficially (as that term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended) 1,004,000 shares of the common stock of Premier Research Worldwide, Ltd., representing 14.7% of the outstanding shares of common stock. Dr. Morganroth's beneficial ownership is as follows: 1. 495,175 shares directly owned by Dr. Morganroth, as to which he has sole voting and dispositive power. 2. 9,600 shares owned by a pension plan, as to which Dr. Morganroth has shared voting and dispositive power. 3. 4,000 shares underlying currently exercisable options granted under a Corporation stock option plan. 4. 495,225 shares held in a trust, the trustee of which is Dr. Morganroth's wife and the beneficiaries of which are Dr. Morganroth's children. Dr. Morganroth disclaims beneficial ownership of these shares. -3- Signature --------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in my statement is true, complete and correct. Dated: September 1, 1999 /s/ Joel Morganroth, M.D. ------------------------- [Signature] Joel Morganroth, M.D. ------------------------- Name/Title -4- -----END PRIVACY-ENHANCED MESSAGE-----